Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Stacey B Trooskin, MD, PhD, MPH

Clinical Assistant Professor of Medicine
Attending Physician, Penn Presbyterian Medical Center
Department: Medicine

Contact information
Philadelphia Fight
1233 Locust Street
Philadelphia, PA 19107
Education:
BS (Biology)
University of Pennsylvania, 1998.
MPH (Epidemiology of Microbial Disease)
Yale University, School of Epidemiology and Public Health, 2001.
PhD (Epidemiology)
Rutgers School of Public Health, 2005.
MD
University of Medicine and Dentistry of New Jersey Robert Wood Johnson School of Medicine , 2007.
Post-Graduate Training
Residency in Internal Medicine, Hospital of the University of Pennsylvania, 2007-2010.
Fellowship in Infectious Diseases, Hospital of the University of Pennsylvania, 2010-2012.
Certifications
Internal Medicine, 2012.
Infectious Diseases, 2014.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Spaulding AC, Graham CS, Akiyama MJ, Chhatwal J, Nijhawan AE, Ninburg MH, Rich JD, Strick LB, Taylor LE, Trooskin SB, Westergaard RP, Sabol WJ: Letter to the Editor: Hepatitis C Virus Prevalence Estimates Among Incarcerated Persons. Hepatology 70(2): 758-759, Aug 2019.

Day E, Broder T, Bruneau J, Cruse S, Dickie M, Fish S, Grillon C, Luhmann N, Mason K, McLean E, Trooskin S, Treloar C, Grebely J: Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs. Int J Drug Policy 66: 87-93, May 2019.

Day E, Hellard M, Treloar C, Bruneau J, Martin NK, ├śvrehus A, Dalgard O, Lloyd A, Dillon J, Hickman M, Byrne J, Litwin A, Maticic M, Bruggmann P, Midgard H, Norton B, Trooskin S, Lazarus JV, Grebely J, International Network on Hepatitis in Substance Users (INHSU): Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework. Liver Int 39(1): 20-30, Jan 2019.

Ramers CB, Trooskin SB: Hepatitis C Virus in the Modern Direct-Acting Antiviral Era: Where Have All the Special Populations Gone? Clin Liver Dis 12(5): 143-149, Nov 2018.

Gowda C, Lott S, Grigorian M, Carbonari DM, Saine ME, Trooskin S, Roy JA, Kostman JR, Urick P, Lo Re V 3rd: Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study. Open Forum Infect Dis 5(6): ofy076, Jun 2018.

Graham CS, Trooskin SB: Removing the Barriers from the Path to Eliminate Hepatitis C. Infect Dis Clin North Am 32(2): xv-xvi, Jun 2018.

Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, Krok K, Centkowski S, Dalldorf K, D'souza J, Halegoua-De Marzio D, Goldberg DS, Trooskin S, Levine LD, Srinivas SK, Lewis JD, Forde KA, Lo Re V: Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: A regional hospital-based cohort study. Liver Int 38(5): 813-820, May 2018.

Nunn A, Brinkley-Rubinstein L, Rose J, Mayer K, Stopka T, Towey C, Harvey J, Santamaria K, Sabatino K, Trooskin S, Chan PA: Latent class analysis of acceptability and willingness to pay for self-HIV testing in a United States urban neighbourhood with high rates of HIV infection J Int AIDS Soc 20(1): 21290, Jan 2017.

Hom J, Coleman CR, Dougherty M, Magaldi L, Preston TL, Trooskin SB: The role of community-based hepatitis C testing in reaching young, at-risk adults. American Association for the Study of Liver Disease 2016 Meeting, Boston, MA Nov 2016 Notes: Poster Presentation.

Trooskin SB: HCV Testing and Linkage to Care. HepCURE Webinar Nov 2016.

back to top
Last updated: 09/20/2019
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration